NSYS vs. KE: Which Electronics Manufacturing Stock Is the Better Buy?

The electronics manufacturing services (EMS) industry continues to evolve, supported by growing demand for advanced electronic products, increasing outsourcing by original equipment manufacturers and the need for efficient supply-chain solutions. Companies are investing in manufacturing capabilities, engineering expertise and operational efficiency to meet changing customer requirements across various industries. Against this backdrop, Nortech Systems Incorporated NSYS and Kimball Electronics, Inc. KE are two companies providing electronics manufacturing and engineering solutions to customers across multiple markets. Nortech offers engineering design, contract manufacturing, electronic assemblies and supply-chain management services, primarily serving the medical device, medical imaging, aerospace and defense, and industrial markets. Kimball Electronics provides electronics manufacturing, engineering support, medical device manufacturing and integrated manufacturing solutions, primarily serving the automotive, medical and industrial markets.

While both companies operate within the broader EMS industry, they differ in their manufacturing scale, end-market exposure and business strategies. Their distinct operational capabilities, customer bases and growth approaches create different investment profiles, raising the question: which company is better positioned to create long-term shareholder value? Let's take a closer look.

Factors Driving Nortech Stock

Nortech's growing order backlog provides improved visibility into future revenues, supported by increasing orders from aerospace and defense and medical imaging customers. Stronger medical device demand, new program ramp-ups and higher orders from existing customers are creating additional growth opportunities. NSYS' ability to secure new business and maintain customer relationships could support sustained revenue growth as backlog converts into shipments.

Nortech continues to benefit from restructuring initiatives undertaken in late 2024 and early 2025, aimed at streamlining operations, optimizing production capacity and reducing costs. Improved manufacturing utilization and higher production activity have strengthened fixed-cost absorption, contributing to better gross margins and operating profitability in the first half of 2026. Additionally, available capacity across existing facilities could accommodate higher production volumes without significant capital investments, potentially enhancing operating leverage and supporting sustainable margin improvement.

Nortech's continued investments in fiber-optic technologies and advanced connectivity solutions create long-term growth opportunities. Its Power Over Fiber, Digital Diagnostics Xtreme and SkyIoT platforms are designed to address customer requirements for lighter, faster and more reliable connectivity. These technologies support applications that require high-speed data transmission, real-time diagnostics and improved system performance. Continued innovation could strengthen NSYS' competitive positioning in medical, aerospace and defense markets while supporting its shift toward higher-value engineering solutions.

Factors Aiding Kimball Electronics Stock

Kimball Electronics continues to benefit from healthy demand across its medical business, particularly surgical devices, in vitro diagnostics, patient monitoring and drug delivery products. The medical segment recorded sustained growth throughout fiscal 2026, supported by customer demand across multiple regions. Management expects continued organic growth across most medical product categories, including respiratory care and imaging. This momentum could help KE increase its medical market exposure, reduce reliance on automotive revenues and achieve a more balanced business portfolio.

Kimball Electronics' acquisition of Helvoet Polymer Technologies strengthens its contract development and manufacturing organization (CDMO) capabilities. The transaction adds expertise in precision molded plastics, complex tooling and medical device components while expanding its manufacturing presence in Europe and India. Combined with its new Indianapolis medical facility, these capabilities broaden KE's integrated manufacturing offerings. They also enhance its ability to support complex customer requirements across the medical and pharmaceutical industries, potentially strengthening its competitive position.

Kimball Electronics' consistent operating cash generation and improving working capital efficiency are supporting a stronger financial position. Better cash conversion has enabled debt reduction, while lower borrowing levels and interest costs are providing additional support to profitability. KE also continues to return capital to shareholders through share repurchases. Its available liquidity and borrowing capacity provide flexibility to fund capital investments, pursue strategic acquisitions and support long-term growth initiatives without compromising financial discipline.

Choose KE Over NSYS Now

Nortech and Kimball Electronics present contrasting investment profiles, particularly in terms of financial resilience, operational maturity and the risks associated with sustaining growth. While NSYS offers opportunities for operational improvement and future expansion, its investment appeal depends on consistent execution and stronger cash generation. KE, meanwhile, benefits from a more established operating foundation and greater financial flexibility, providing a relatively stable platform for pursuing long-term growth.

For investors, the distinction lies in the balance between potential growth opportunities and the financial strength required to capitalize on them. Nortech could benefit from converting its growing backlog into revenues and leveraging existing production capacity to improve profitability. However, sustaining these improvements will require consistent execution and better cash generation. Kimball Electronics' stronger financial position provides greater flexibility to pursue strategic investments, expand its medical CDMO business and navigate demand fluctuations across its automotive and industrial markets.

Considering these factors, KE appears to be the better buy. Its established global manufacturing operations, strengthening medical business and greater financial flexibility support a more balanced risk-reward proposition. Although Nortech offers opportunities through operational improvements and technological innovation, KE presents a more defensible investment case for investors seeking sustainable long-term growth with relatively lower financial risk.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research